Decreased rates of transmission of drug-resistant HIV-1 strains containing the M184V mutation in reverse transcriptase

被引:0
|
作者
Turner, D
Brenner, BG
Routy, JP
Moisi, D
Wainberg, MA
机构
[1] McGill Univ, AIDS Ctr, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
129
引用
收藏
页码:U123 / U124
页数:2
相关论文
共 50 条
  • [31] HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1
    Starodubova, Elizaveta
    Boberg, Andreas
    Kashuba, Elena V.
    Wahren, Britta
    Karpov, Vadim
    Isaguliants, Maria
    VACCINE, 2006, 24 (21) : 4541 - 4547
  • [32] Revealing the Drug-Resistant Mechanism for Diarylpyrimidine Analogue Inhibitors of HIV-1 Reverse Transcriptase
    Zhang, Hao
    Qin, Fang
    Ye, Wei
    Li, Zeng
    Ma, Songyao
    Xia, Yan
    Jiang, Yi
    Zhu, Jiayi
    Li, Yixue
    Zhang, Jian
    Chen, Hai-Feng
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (03) : 427 - 437
  • [33] The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors
    Miller, V
    Stürmer, M
    Staszewski, S
    Gröschel, B
    Hertogs, K
    de Béthune, MP
    Pauwels, R
    Harrigan, PR
    Bloor, S
    Kemp, SD
    Larder, BA
    AIDS, 1998, 12 (07) : 705 - 712
  • [34] The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus
    Whitney, JB
    Oliveira, M
    Detorio, M
    Guan, YJ
    Wainberg, MA
    JOURNAL OF VIROLOGY, 2002, 76 (17) : 8958 - 8962
  • [35] Distinctive Drug-resistant Mutation Profiles and Interpretations of HIV-1 Proviral DNA Revealed by Deep Sequencing in Reverse Transcriptase
    Yin Qian Qian
    Li Zhen Peng
    Zhao Hai
    Pan Dong
    Wang Yan
    Xu Wei Si
    Xing Hui
    Feng Yi
    Jiang Shi Bo
    Shao Yi Ming
    Ma Li Ying
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2016, 29 (04) : 239 - 247
  • [36] Distinctive Drug-resistant Mutation Profiles and Interpretations of HIV-1 Proviral DNA Revealed by Deep Sequencing in Reverse Transcriptase
    YIN Qian Qian
    LI Zhen Peng
    ZHAO Hai
    PAN Dong
    WANG Yan
    XU Wei Si
    XING Hui
    FENG Yi
    JIANG Shi Bo
    SHAO Yi Ming
    MA Li Ying
    Biomedical and Environmental Sciences, 2016, 29 (04) : 239 - 247
  • [37] Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication
    Naeger, LK
    Margot, NA
    Miller, MD
    ANTIVIRAL THERAPY, 2001, 6 (02) : 115 - 126
  • [38] Interactions of enantiomers of 2',3'-didehydro-2',3'-dideoxyfluorocytidine with wild type and M184V mutant HIV-1 reverse transcriptase
    Ray, AS
    Murakami, E
    Peterson, CN
    Shi, JX
    Schinazi, RF
    Anderson, KS
    ANTIVIRAL RESEARCH, 2002, 56 (03) : 189 - 205
  • [39] Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase
    Berkhout, Ben
    Back, Nicole K. T.
    de Ronde, Anthony
    Jurriaans, Suzanne
    Bakker, Margreet
    Parkin, Neil T.
    van der Hoek, Lia
    AIDS, 2006, 20 (11) : 1515 - 1520
  • [40] Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants
    Dykes, C
    Fox, K
    Lloyd, A
    Chiulli, M
    Morse, E
    Demeter, LM
    VIROLOGY, 2001, 285 (02) : 193 - 203